Arbutus Biopharma Corporation - SIC # 2830 -

Ticker Exchange SIC # Website Latest Ticker
ABUS Nasdaq 2830 www.arbutusbio.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Arbutus Biopharma Corporation

Arbutus Reacquires Greater China Rights to Imdusiran and Announces Scientific Advisory Board with Late-Stage Clinical Focus - Jun 25th, 2025 5:30 am
Arbutus Biopharma (ABUS) Reports Q1 Loss, Tops Revenue Estimates - May 14th, 2025 6:45 am
Arbutus: Q1 Earnings Snapshot - May 14th, 2025 5:39 am
Arbutus Reports First Quarter 2025 Financial Results and Provides Corporate Update - May 14th, 2025 5:30 am
Is Editas Medicine (EDIT) Stock Outpacing Its Medical Peers This Year? - May 13th, 2025 7:40 am
Arbutus Presents Clinical Trial Data from its Two HBV Assets, Imdusiran and AB-101, at the European Association for the Study of the Liver (EASL) Congress 2025 - May 7th, 2025 12:01 am
Is Boston Scientific (BSX) Stock Outpacing Its Medical Peers This Year? - Apr 25th, 2025 7:40 am
Will Arbutus Biopharma (ABUS) Report Negative Q1 Earnings? What You Should Know - Apr 24th, 2025 8:02 am
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025 - Apr 23rd, 2025 12:01 am
All You Need to Know About Arbutus (ABUS) Rating Upgrade to Buy - Mar 31st, 2025 10:00 am
Is Arbutus Biopharma (ABUS) Outperforming Other Medical Stocks This Year? - Mar 31st, 2025 7:40 am
Novo gains Lexicon obesity drug; CRISPR COO to step down - Mar 28th, 2025 5:01 am
Arbutus Biopharma (ABUS) Reports Q4 Loss, Tops Revenue Estimates - Mar 27th, 2025 6:45 am
Arbutus Reports Fourth Quarter and Year End 2024 Financial Results and Provides Corporate Update - Mar 27th, 2025 5:30 am
Roivant Sciences Unit, Arbutus File Lawsuits Against Moderna for Alleged Patent Infringement - Mar 3rd, 2025 8:07 am
Genevant Sciences and Arbutus Biopharma Initiate International Patent Infringement Enforcement Actions Against Moderna - Mar 3rd, 2025 7:15 am
Arbutus Announces Changes to Board of Directors and Appointment of Lindsay Androski as CEO - Feb 25th, 2025 5:00 am
Is Arbutus Biopharma Corp. (ABUS) the Best Nasdaq Stock Under $5 to Buy? - Feb 12th, 2025 7:24 am
Jim Cramer on Arbutus Biopharma Corporation (ABUS): ‘It Loses Money’ - Jan 16th, 2025 9:22 am
Kymera Therapeutics (KYMR) Moves 7.8% Higher: Will This Strength Last? - Jan 15th, 2025 7:38 am